Diabetic injection pen are used to inject insulin for the treatment of diabetes. Insulin is a hormone produced by the pancreas. It is composed of an insulin cartridge (integrated or bought separately) and a dial to measure the dose, and is used with disposable pen needles to deliver the dose.
This report contains market size and forecasts of Diabetic Injection Pen in global, including the following market information:
Global Diabetic Injection Pen Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diabetic Injection Pen Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Diabetic Injection Pen companies in 2021 (%)
The global Diabetic Injection Pen market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Reusable Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Injection Pen include Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca Plc, Biocon Ltd., Sanofi S.A., Becton，Dickinson and Company, Owen Mumford Ltd., Jiangsu Delfu Co. and Wockhardt Ltd.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetic Injection Pen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Injection Pen Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetic Injection Pen Market Segment Percentages, by Type, 2021 (%)
Reusable Pens
Disposable Pens
Global Diabetic Injection Pen Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetic Injection Pen Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Sales
Diabetes Clinics/ Centers
Global Diabetic Injection Pen Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Diabetic Injection Pen Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Injection Pen revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diabetic Injection Pen revenues share in global market, 2021 (%)
Key companies Diabetic Injection Pen sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Diabetic Injection Pen sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk A/S
Eli Lilly and Company
AstraZeneca Plc
Biocon Ltd.
Sanofi S.A.
Becton，Dickinson and Company
Owen Mumford Ltd.
Jiangsu Delfu Co.
Wockhardt Ltd.